TW9
TW9 is a dual BRD4-BD2 and HDAC1 inhibitor with selectivity over BRD4-BD1 and HDAC2. It induces apoptosis and G1 cell cycle arrest in pancreatic cancer cell lines and acts synergistically with gemcitabine, supporting its investigation as an anticancer research tool.
Product Specifications
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
